[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 27, n. 1, 2026. DOI: 10.7175/fe.v27i1.1605. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1605. Acesso em: 25 mar. 2026.